1. Search Result
Search Result
Results for "

MB

" in MedChemExpress (MCE) Product Catalog:

358

Inhibitors & Agonists

4

Fluorescent Dye

3

Biochemical Assay Reagents

8

Peptides

7

Inhibitory Antibodies

35

Natural
Products

14

Recombinant Proteins

3

Isotope-Labeled Compounds

6

Antibodies

5

Click Chemistry

7

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-19513

    Thyroid Hormone Receptor Metabolic Disease Endocrinology
    MB-07344 is a potent thyroid hormone receptor (TR)-β agonist with a Ki of 2.17 nM. MB-07344 has additive cholesterol lowering activity in combination with Atorvastatin (HY-B0589) in rabbits, dogs and monkeys .
    MB-07344
  • HY-19513A

    Thyroid Hormone Receptor Metabolic Disease Endocrinology
    MB-07344 sodium is a potent thyroid hormone receptor (TR)-β agonist with a Ki of 2.17 nM. MB-07344 sodium has additive cholesterol lowering activity in combination with Atorvastatin (HY-B0589) in rabbits, dogs and monkeys .
    MB-07344 sodium
  • HY-111288

    VK-2809

    Thyroid Hormone Receptor Metabolic Disease Endocrinology
    MB-07811 (VK-2809) is an orally active HepDirect prodrug of MB07344, a liver-targeted thyroid hormone receptor-β agonist . MB-07811 has cholesterol and triglycerides lowering activity .
    MB-07811
  • HY-136289

    Drug-Linker Conjugates for ADC Cancer
    MB-VC-MGBA is a agent-linker conjugate for ADC with potent antitumor activity by using MGBA (minor-groove-binding DNA-alkylating agent), linked via the ADC linker MB-VC .
    MB-VC-MGBA
  • HY-118820

    M&B 28767

    Prostaglandin Receptor Inflammation/Immunology
    MB-28767 (M&B 28767) is an EP3 receptor agonist .
    MB-28767
  • HY-16311

    DNA/RNA Synthesis Cancer
    MB-7133 is a DNA synthesis inhibitor.
    MB-7133
  • HY-P990622

    Transmembrane Glycoprotein Inflammation/Immunology
    MB-311 is a humanized antibody expressed in CHO cells, targeting Lewis Y. MB-311 has a huIgG1 heavy chain and a huλ light chain, with a predicted molecular weight (MW) of 150 kDa. The isotype control for MB-311 can refer to Human IgG1 kappa, Isotype Control (HY-P99001).
    MB-311
  • HY-P991072

    MAPP-66

    HIV HSV Infection
    MB-66 (MAPP-66) is a fully human IgG1 antibody that targets HSV and HIV. MB-66 is a monoclonal antibody film for vaginal application. The isotype control for MB-66 can refer to Human IgG1 kappa, Isotype Control (HY-P99001) .
    MB-66
  • HY-161118

    Others Neurological Disease
    MB327 is a bipyridine nonoxime compound that restores neuromuscular function. MB327 restores the activity of nicotinamide acetylcholine receptors (nAChRs) for carbachol desensitization in a typical type II PAM manner. MB327 can neutralize nerve agent poisoning .
    MB327
  • HY-155011

    Bacterial Antibiotic Others
    MB076 is a novel heterocyclic triazole with improved plasma stability. MB076 inhibits seven different Class C Acinetobacter-derived cephalosporinases (ADCs) β-lactamase variants with Ki values < 1 μM. MB076 acts synergistically in combination with multiple cephalosporins to restore pBCSK(−) susceptibility .
    MB076
  • HY-109071

    MB-102

    Others Others
    Relmapirazin (MB-102) is a fluorescent tracer agent for real-time measurement of glomerular filtration rate .
    Relmapirazin
  • HY-D2741

    Fluorescent Dye Others
    MB 488 NHS ester is a fluroescent agent with a terminal NHS ester group. MB 488 NHS ester is a green fluorescent, very hydrophilic dye molecule that has a maximal absorption of 501 nm and emission at 524 nm. The NHS ester can be applied to label the primary amines (-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules.
    MB 488 NHS ester
  • HY-16309

    Phosphatase Metabolic Disease
    MB07803 is an orally available prodrug of a potent, noncompetitive inhibitor (MB07729) of fructose 1,6-bisphosphatase (FBPase), with EC50 of 140 nM and t1/2 of 7.6±2.9 h.
    MB-07803
  • HY-120373
    MB710
    1 Publications Verification

    MDM-2/p53 Cancer
    MB710, an aminobenzothiazole derivative, is a stabilizer of oncogenic p53 mutation Y220C. MB710 binds tightly to the Y220C pocket and stabilizes p53-Y220C, with a Kd of 4.1 μM. MB710 shows anticancer activity in p53-Y220C cell lines .
    MB710
  • HY-W800770

    Fluorescent Dye Others
    MB 543 DBCO is a fluroescent agent with a terminal DBCO group. The DBCO group is commonly used for copper-free Click Chemistry reactions due to its strain promoted high energy. MB 543 Alkyne is a very hydrophilic, water-soluble, orange fluorescent dye that has a maximal absorption of 543 nm and emission at 566 nm. The compound is also pH insensitive from pH 3 to pH 10.
    MB 543 DBCO
  • HY-131037

    Dynamin Cancer
    MB-0223 is a potent and selective dynamin-related GTPase Drp1 partial inhibitor (IC50=1.3 μM) over other dynamin family members, Opa 1 and dynamin-1 (IC50>100 μM) .
    MB-0223
  • HY-16307
    MB05032
    5 Publications Verification

    FBPase Metabolic Disease
    MB05032 is a special and efficacious gluconeogenesis inhibitor targeted the AMP binding site of fructose 1,6-bisphosphatase (FBPase) with an IC50 value of 16 nM.
    MB05032
  • HY-W800832

    Fluorescent Dye Others
    MB 660R DBCO is a bright and photostable far-red dye that emits fluorescence at about 685 nm in the borderline spectral region between far-red and near-IR. Although the absorption maximum is at around 665 nm, this dye can be sufficiently excited by the 633 or 635 nm laser. MB 660R DBCO is water soluble and pH-insensitive from pH 4 to pH 10. MB 660R DBCO is a rhodamine-based dye, and like rhodamine dyes in general, it is very bright and exceptionally photostable.
    MB 660R DBCO
  • HY-D2767

    Fluorescent Dye Others
    MB 660R NHS Ester is a fluroescent agent with a terminal NHS ester group.MB 660R NHS Ester is a far-red fluorescent dye that has a maximal absorption of 665 nm and emission at 690 nm. The NHS ester can be applied to label the primary amines (-NH2) of proteins, amine-modified oligonucleotides, and other amine-containing molecules.
    MB 660R NHS Ester
  • HY-RS08179

    Small Interfering RNA (siRNA) Others

    MB Human Pre-designed siRNA Set A contains three designed siRNAs for MB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    MB Human Pre-designed siRNA Set A
    MB Human Pre-designed siRNA Set A
  • HY-RS23123

    Small Interfering RNA (siRNA) Others

    Mb Rat Pre-designed siRNA Set A contains three designed siRNAs for Mb gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Mb Rat Pre-designed siRNA Set A
    Mb Rat Pre-designed siRNA Set A
  • HY-RS16688

    Small Interfering RNA (siRNA) Others

    Mb Mouse Pre-designed siRNA Set A contains three designed siRNAs for Mb gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Mb Mouse Pre-designed siRNA Set A
    Mb Mouse Pre-designed siRNA Set A
  • HY-14955

    MB06322; CS-917

    FBPase Metabolic Disease
    Managlinat dialanetil (MB06322) is an orally bioavailable inhibitor of fructose 1,6-bisphosphatase (FBPase) for the treatment of type 2 diabetes .
    Managlinat dialanetil
  • HY-RS08180

    Small Interfering RNA (siRNA) Others

    MB21D2 Human Pre-designed siRNA Set A contains three designed siRNAs for MB21D2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    MB21D2 Human Pre-designed siRNA Set A
    MB21D2 Human Pre-designed siRNA Set A
  • HY-129039
    Butyrolactone 3
    5+ Cited Publications

    MB-3

    Histone Acetyltransferase Neurological Disease Metabolic Disease Inflammation/Immunology Cancer
    Butyrolactone 3 (MB-3) is a specifical small-molecule inhibitor of the histone acetyltransferase Gcn5 (IC50=100 μM), which has a high affinity to the Gcn5 enzyme comparable to that of its natural substrate, histone H3. Butyrolactone 3 shows weak inhibitory on CBP (IC50=0.5 mM). Butyrolactone 3 can be used in studies of cancer, metabolic, autoimmune and neurological diseases .
    Butyrolactone 3
  • HY-139577A

    MB-1018972 trihydrochloride; IMB-101 trihydrochloride

    Mitochondrial Metabolism Cardiovascular Disease Metabolic Disease
    Ninerafaxstat trihydrochloride (IMB-1018972 trihydrochloride) is the trihydrochloride salt form of Ninerafaxstat (HY-139577). Ninerafaxstat trihydrochloride is a novel orally active cardiac mitochondrial drug that restores myocardial energy homeostasis. Ninerafaxstat trihydrochloride competitively inhibits 3-ketoacyl-CoA thiolase (3-KAT) to partially suppress fatty acid oxidation, and shifts cardiac energy metabolism from free fatty acid oxidation to glucose oxidation, regulating myocardial substrate utilization and thereby improving cardiac efficiency. Ninerafaxstat trihydrochloride can be used for research on cardiovascular diseases .
    Ninerafaxstat trihydrochloride
  • HY-112842
    MBQ-167
    5+ Cited Publications

    Ras CDK Cancer
    MBQ-167 is a dual Rac/Cdc42 inhibitor, with IC50s of 103 nM for Rac 1/2/3 and 78 nM for Cdc42 in MDA-MB-231 cells, respectively.
    MBQ-167
  • HY-P2799D

    CK-MB

    Biochemical Assay Reagents Others
    Creatine Kinase MB (rCK-MB), Recombinant Human (CK-MB) is a biological material or organic compound that can be used in life science research .
    Creatine Kinase MB (rCK-MB), Recombinant Human
  • HY-149710

    ICMT ERK Cancer
    POP-3MB (compound 1b) is an ICMT inhibitor (IC50: 2.5 μM). POP-3MB changes the subcellular localization of K-Ras and inhibits Ras activation. POP-3MB also inhibits Erk phosphorylation .
    POP-3MB
  • HY-107770

    ADC Cytotoxin DNA Alkylator/Crosslinker Cancer
    Duocarmycin MB is an antibody agent conjugates (ADCs) toxin. Duocarmycin is a DNA alkylating agent that binds in the minor groove. Duocarmycin MB can be used against multi-agent resistant cell lines.
    Duocarmycin MB
  • HY-163290

    Fluorescent Dye Monoamine Oxidase Cancer
    HDAC-MB a probe that is activated by HDAC6 and can detect and eliminate glioma cells through activation by HDAC6. HDAC-MB reveals antimetastatic and antiproliferative properties, inhibits glioma invasion and induces cellular apoptosis .
    HDAC-MB
  • HY-146676

    BCRP Cancer
    UR-MB108 (Compound 57) is a potent, selective ABCG2 (BCRP) inhibitor with an IC50 of 79 nM. UR-MB108 is stable in blood plasma .
    UR-MB108
  • HY-149843

    FGFR PROTACs Cancer
    LC-MB12 is an orally active PROTAC compound targets FGFR2 degradation with a DC50 of 11.8 nM. LC-MB12 contains BGJ398 (a FGFR2 inhibitor), PROTAC linker and CRBN.LC-MB12 inhibits FGFR2 signaling in gastric cancer cells and has anti-tumor activity .
    LC-MB12
  • HY-151388

    Monoamine Oxidase COMT Neurological Disease
    hMAO-B/MB-COMT-IN-1 is a dual MAO-B/MB-COMT inhibitor (IC50s: 2.5 μΜ for hMAO-B, 3.84 μΜ for MB-COMT). hMAO-B/MB-COMT-IN-1 protects cells against oxidative damage. hMAO-B/MB-COMT-IN-1 can be used in the research of neurodegeneration disease, such as Parkinson’s Disease (PD) .
    hMAO-B/MB-COMT-IN-1
  • HY-151390

    Monoamine Oxidase COMT Neurological Disease
    hMAO-B/MB-COMT-IN-2 is a dual MAO-B/MB-COMT inhibitor (IC50s: 4.27 μΜ for hMAO-B, 2.69 μΜ for MB-COMT). hMAO-B/MB-COMT-IN-2 protects cells against oxidative damage. hMAO-B/MB-COMT-IN-2 can be used in the research of neurodegeneration disease, such as Parkinson’s Disease (PD) .
    hMAO-B/MB-COMT-IN-2
  • HY-102069

    Polo-like Kinase (PLK) CDK DAPK Others
    3MB-PP1, a bulky purine analog, is a Polo-like kinase 1 (Plk1) inhibitor. 3MB-PP1 blocks mitotic progression and cell division arise through target Plk1 in in cells expressing analog-sensitive Plk1 alleles. 3MB-PP1 specifically inhibits the activity of analog-sensitive Ssn3 (Cdk8). 3MB-PP1 inhibits Leu93 Mutant Zipper-interacting protein kinase (Leu93-ZIPK; IC50=2 μM). 3MB-PP1 can be used for the research of hypha formation of Candida albicans and cell division .
    3MB-PP1
  • HY-134395

    N6-Monobutyryl-cAMP

    Biochemical Assay Reagents Others
    6-MB-cAMP is a cAMP agonist. 6-MB-cAMP is a membrane permeable analog of cAMP .
    6-MB-cAMP
  • HY-131508

    Parasite Infection
    M&B 5124 is a potent inhibitor of Schistosoma mansoni in mice .
    M&B 5124
  • HY-119331

    Apoptosis Cancer
    CFM-5 inhibits CARP-1/CCAR1-APC-2 interaction with an IC50 value of 0.75 μM. CFM-5 inhibits medulloblastoma (MB) cell proliferation and induces apoptosis .
    CFM-5
  • HY-131764

    2′-O-Monobutyryl-cGMP sodium

    Phosphodiesterase (PDE) Others
    2'-O-MB-cGMP (2′-O-Monobutyryl-cGMP) sodium is a cyclic GMP-specific phosphodiesterase inhibitor with an I50 value of 35 µM. 2'-O-MB-cGMP (2′-O-Monobutyryl-cGMP) sodium inhibits Ca 2+ dependent phosphodiesterase hydrolysis using cAMP or cGMP as substrate .
    2'-O-MB-cGMP sodium
  • HY-14955A

    (Rac)-MB06322; (Rac)-CS-917

    Others Others
    (Rac)-Managlinat dialanetil ((Rac)-MB06322) is a compound for the inhibition of type 2 diabetes that is in Phase II clinical trials and works by inhibiting gluconeogenesis.
    (Rac)-Managlinat dialanetil
  • HY-131763

    2'-O-Monobutyryl cyclic AMP sodium

    Drug Intermediate Others
    2'-O-MB-cAMP (2'-O-Monobutyryl cyclic AM) sodium is an activatable proagent of Cyclic AMP (HY-B1511) .
    2'-O-MB-cAMP sodium
  • HY-P990267

    Transmembrane Glycoprotein Others
    Anti-Mouse CD45RB Antibody (MB23G2) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD45RB.
    Anti-Mouse CD45RB Antibody (MB23G2)
  • HY-14197
    Clorgyline
    4 Publications Verification

    M&B 9302

    Monoamine Oxidase Neurological Disease
    Clorgyline (M&B 9302) is an orally active, blood-brain barrier permeable and selective monoamine oxidase A (MAO-A) inhibitor. Clorgyline's selective inhibition of MAO-A leads to reduced metabolism of neurotransmitters such as serotonin (5-hydroxytryptamine), which accumulates in the brain. Clorgyline can be used in the study of depression and neurodegenerative diseases .
    Clorgyline
  • HY-160598

    ADC Cytotoxin Topoisomerase Cancer
    Exatecan-amide-bicyclo[1.1.1]pentan-1-ylmethanol (compound 45) is a camptothecin compound that can inhibit cell proliferation, with an IC50 of 2.92 ng/mL for MDA‑MB‑468 cells. Exatecan-amide-bicyclo[1.1.1]pentan-1-ylmethanol can be used for the research of cancer .
    Exatecan-amide-bicyclo[1.1.1]pentan-1-ylmethanol
  • HY-B1816
    Zaprinast
    2 Publications Verification

    M&B 22948

    Phosphodiesterase (PDE) GPR35 Cardiovascular Disease Neurological Disease Endocrinology
    Zaprinast (M&B 22948) is a selective inhibitor of cGMP-selective Phosphodiesterase (PDE5). Zaprinast causes a significant increase in cGMP levels in myocytes. Zaprinast is a G protein-coupled receptor 35 (GPR35) agonist which activates rat GPR35 strongly and activates human GPR35 moderately. Zaprinast reduces vessel remodeling through antiproliferative and proapoptotic effects .
    Zaprinast
  • HY-164500

    Apoptosis Histone Methyltransferase Cancer
    MC3629 is an inhibitor of histone methyltransferase (EZH2) with anti-tumor activity. MC3629 inhibits SHH MB cancer cell proliferation and self-renewal and induces apoptosis. MC3629 can be used to study drug resistance in tumor aggressiveness .
    MC3629
  • HY-N10965

    Others Cancer
    Gambogic acid B is an active compound. Gambogic acid B can be isolated from the resin of Garcinia hanburyi.. Gambogic acid B has cytotoxicity against A549, HCT116 and MDA MB 231 cells with IC50 values of 1.60 μM, 6.88 μM and 0.87 μM, respectively .
    Gambogic acid B
  • HY-N0247

    Hedgehog Smo STAT Interleukin Related TNF Receptor Inflammation/Immunology Cancer
    Saikosaponin B1 is a bioactive constituent of Radix Bupleuri. Saikosaponin B1 is an agonist of the 5-HT2C receptor with an EC50 of 147.41 μM. Saikosaponin B1 inhibits the Hedgehog (Hh) signaling pathway by targeting the transmembrane protein SMO. Sailosaponin B1 can reduce liver fibrosis. Saikosaponin B1 has anti-cancer activities thus can be studies in research for cancers such as Medulloblastoma (MB) .
    Saikosaponin B1
  • HY-143877

    HDAC Cancer
    NN-390 is a potent and selective HDAC6 inhibitor, with an IC50 of 9.8 nM. NN-390 penetrates the blood-brain barrier (BBB). NN-390 shows study potential in metastatic Group 3 MB (medulloblastoma) .
    NN-390

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: